Article: Outsourcing biologics: key considerations

PCI’s Tim Roberts discusses key factors when outsourcing the clinical and commercial supply of biologics, and what makes a strong CDMO partnership.

Biologics are a more complex class of medicines to manufacture, package, store and distribute than their chemical counterparts. Outsourcing of any aspect of the supply chain means pharmaceutical companies and their chosen vendors need to work in true partnership, navigating the complex process together to ensure speed to market. Tim Roberts, Chief Commercial Officer at PCI Pharma Services, explains some of the key considerations when partnering with a CDMO for the supply of biologic medicines.